MA29088B1 - Composes d'indazole-carboxamide. - Google Patents
Composes d'indazole-carboxamide.Info
- Publication number
- MA29088B1 MA29088B1 MA29976A MA29976A MA29088B1 MA 29088 B1 MA29088 B1 MA 29088B1 MA 29976 A MA29976 A MA 29976A MA 29976 A MA29976 A MA 29976A MA 29088 B1 MA29088 B1 MA 29088B1
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- indazole
- carboxamide compounds
- carboxamide
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Developing Agents For Electrophotography (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63880004P | 2004-12-22 | 2004-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA29088B1 true MA29088B1 (fr) | 2007-12-03 |
Family
ID=36295339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA29976A MA29088B1 (fr) | 2004-12-22 | 2007-06-08 | Composes d'indazole-carboxamide. |
Country Status (19)
Country | Link |
---|---|
US (3) | US7419989B2 (fr) |
EP (1) | EP1831211B1 (fr) |
JP (1) | JP5159317B2 (fr) |
KR (1) | KR20070091665A (fr) |
CN (1) | CN101080406A (fr) |
AT (1) | ATE469897T1 (fr) |
AU (1) | AU2005319190A1 (fr) |
BR (1) | BRPI0519708A2 (fr) |
CA (1) | CA2588037A1 (fr) |
DE (1) | DE602005021696D1 (fr) |
ES (1) | ES2347265T3 (fr) |
IL (1) | IL183160A0 (fr) |
MA (1) | MA29088B1 (fr) |
MX (1) | MX2007007818A (fr) |
NO (1) | NO20073182L (fr) |
NZ (1) | NZ555180A (fr) |
RU (1) | RU2404179C2 (fr) |
WO (1) | WO2006069125A1 (fr) |
ZA (1) | ZA200705115B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070060606A1 (en) * | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
JP5042028B2 (ja) * | 2004-11-05 | 2012-10-03 | セラヴァンス, インコーポレーテッド | キノリノン−カルボキサミド化合物 |
JP5086091B2 (ja) * | 2004-11-05 | 2012-11-28 | セラヴァンス, インコーポレーテッド | 5−ht4受容体アゴニスト化合物 |
TW200640921A (en) * | 2005-02-17 | 2006-12-01 | Theravance Inc | Crystalline form of an indazole-carboxamide compound |
WO2006094063A1 (fr) * | 2005-03-02 | 2006-09-08 | Theravance, Inc. | Composes de quinolinone en tant qu’agonistes des recepteurs de 5-ht4 |
EP1902053B1 (fr) * | 2005-06-07 | 2011-01-12 | Theravance, Inc. | Composes de benzoimidazolone-carboxamide en tant qu'agonistes du recepteur 5-ht4 |
MY143574A (en) * | 2005-11-22 | 2011-05-31 | Theravance Inc | Carbamate compounds as 5-ht4 receptor agonists |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
CN101384588B (zh) * | 2006-02-16 | 2011-08-31 | 施万制药 | 制备5-ht4受体激动剂化合物的中间体的方法 |
JPWO2009101917A1 (ja) * | 2008-02-13 | 2011-06-09 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ビシクロアミン誘導体 |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
MX2012002608A (es) | 2009-09-14 | 2012-04-02 | Suven Life Sciences Ltd | Compuesto 1,2-dihidro -2-oxoquinolona como ligandos del receptor 5ht4. |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
WO2011092290A1 (fr) | 2010-02-01 | 2011-08-04 | Novartis Ag | Dérivés de pyrazolo[5,1-b] utilisés en tant qu'antagonistes du récepteur de crf-1 |
WO2011095450A1 (fr) | 2010-02-02 | 2011-08-11 | Novartis Ag | Dérivés de cyclohexylamide à titre d'antagonistes du récepteur crf |
US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
US20140057895A1 (en) * | 2011-06-07 | 2014-02-27 | Kazuhiro Mizuno | Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
CA2867043A1 (fr) | 2012-05-03 | 2013-11-07 | Novartis Ag | Sel de l-malate de derives de 2,7-diaza-spiro[4.5]dec-7-yle et ses formes cristallines a titre d'agonistes des recepteurs de ghreline |
JP2014133739A (ja) * | 2012-12-12 | 2014-07-24 | Dainippon Sumitomo Pharma Co Ltd | インダゾール誘導体またはピロロピリジン誘導体からなる医薬 |
EA029951B1 (ru) * | 2013-12-16 | 2018-06-29 | Сувен Лайф Сайенсиз Лимитед | Соединения индазола в качестве агонистов 5-ht-рецептора |
US20160024057A1 (en) * | 2014-07-25 | 2016-01-28 | Innov17 Llc | Indazole retinoic acid receptor-related orphan receptor modulators and uses thereof |
ES2819286T3 (es) * | 2014-08-16 | 2021-04-15 | Suven Life Sciences Ltd | Proceso para la producción a gran escala de oxalato de 1isopropil3{5[1(3metoxipropil) piperidin4il] [1,3,4]oxadiazol2il}1Hindazol |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
WO2019058393A1 (fr) | 2017-09-22 | 2019-03-28 | Jubilant Biosys Limited | Composés hétérocycliques en tant qu'inhibiteurs de pad |
SG11202003463XA (en) | 2017-10-18 | 2020-05-28 | Jubilant Epipad LLC | Imidazo-pyridine compounds as pad inhibitors |
CN111386265A (zh) | 2017-11-06 | 2020-07-07 | 朱比连特普罗德尔有限责任公司 | 作为pd1/pd-l1活化的抑制剂的嘧啶衍生物 |
MX2020005363A (es) | 2017-11-24 | 2020-10-01 | Jubilant Episcribe Llc | Compuestos heterociclicos como inhibidores de prmt5. |
EP3765453A1 (fr) | 2018-03-13 | 2021-01-20 | Jubilant Prodel LLC | Composés bicycliques utilisés en tant qu'inhibiteurs de l'interaction/activation de pd1/pd-l1 |
JP2020199139A (ja) * | 2019-06-12 | 2020-12-17 | コニカミノルタ株式会社 | 制御装置、放射線撮影システム、制御方法及びプログラム |
CN112805282A (zh) * | 2019-09-12 | 2021-05-14 | 广东东阳光药业有限公司 | 吲唑-甲酰胺衍生物及其用途 |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321378A (en) * | 1979-01-16 | 1982-03-23 | Delalande S.A. | 8-(5-Pyrimidinecarboxamide)nor-tropane derivatives |
EP0200444B1 (fr) * | 1985-04-27 | 1992-11-11 | Beecham Group Plc | Azabicyclononyl-indazole carboxamide ayant une activité antagoniste de la 5-HT |
US4937247A (en) * | 1985-04-27 | 1990-06-26 | Beecham Group P.L.C. | 1-acyl indazoles |
GB8527052D0 (en) * | 1985-11-02 | 1985-12-04 | Beecham Group Plc | Compounds |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
DE3777805D1 (de) * | 1986-11-21 | 1992-04-30 | Glaxo Group Ltd | Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes. |
GB8701022D0 (en) * | 1987-01-19 | 1987-02-18 | Beecham Group Plc | Treatment |
US5223511A (en) * | 1987-09-23 | 1993-06-29 | Boehringer Ingelheim Italia S.P.A. | Benzimidazoline-2-oxo-1-carboxylic acid compounds useful as 5-HT receptor antagonists |
IT1231413B (it) | 1987-09-23 | 1991-12-04 | Angeli Inst Spa | Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht |
IT1226389B (it) * | 1988-07-12 | 1991-01-15 | Angeli Inst Spa | Nuovi derivati ammidinici e guanidinici |
US5017573A (en) * | 1988-07-29 | 1991-05-21 | Dainippon Pharmaceutical Co., Ltd. | Indazole-3-carboxylic acid derivatives |
EP0410509A1 (fr) * | 1989-07-25 | 1991-01-30 | Duphar International Research B.V | Indazole-1H-carboxamides-3 substitués |
JPH045289A (ja) | 1990-04-24 | 1992-01-09 | Hokuriku Seiyaku Co Ltd | アミド化合物 |
JP3122671B2 (ja) * | 1990-05-23 | 2001-01-09 | 協和醗酵工業株式会社 | 複素環式化合物 |
HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
EP0564650B1 (fr) * | 1990-12-28 | 1995-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Derive de quinoline |
NZ243993A (en) | 1991-08-20 | 1994-10-26 | Smithkline Beecham Plc | Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity |
EP0603220A1 (fr) * | 1991-09-12 | 1994-06-29 | Smithkline Beecham Plc | Composes azacycliques utilises comme antagonistes du recepteur 5-ht 4? |
MX9305947A (es) * | 1992-09-29 | 1994-06-30 | Smithkline Beecham Plc | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
EP0670319A4 (fr) * | 1992-11-20 | 1996-01-17 | Thaisho Pharmaceutical Co Ltd | Compose heterocyclique. |
TW251287B (fr) | 1993-04-30 | 1995-07-11 | Nissei Co Ltd | |
GB9310582D0 (en) * | 1993-05-22 | 1993-07-07 | Smithkline Beecham Plc | Pharmaceuticals |
CA2184366A1 (fr) * | 1994-02-28 | 1995-08-31 | Yutaka Ohuchi | Compose heterocyclique |
US5864039A (en) * | 1994-03-30 | 1999-01-26 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoic acid compounds and use thereof as medicaments |
GB9406857D0 (en) * | 1994-04-07 | 1994-06-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
JP3829879B2 (ja) * | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
CA2160420A1 (fr) * | 1994-10-20 | 1996-04-21 | Haruhiko Kikuchi | Agonistes du recepteur 5-ht4 |
JP3829880B2 (ja) | 1994-12-27 | 2006-10-04 | 大正製薬株式会社 | 化学中間体 |
IT1275903B1 (it) * | 1995-03-14 | 1997-10-24 | Boehringer Ingelheim Italia | Esteri e ammidi della 1,4-piperidina disostituita |
US5654320A (en) * | 1995-03-16 | 1997-08-05 | Eli Lilly And Company | Indazolecarboxamides |
EP0829474B1 (fr) * | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Derives de l'indazole a groupe amino monocyclique |
ES2109190B1 (es) | 1996-03-22 | 1998-07-01 | Univ Madrid Complutense | Nuevos derivados de bencimidazol con afinidad por los receptores serotoninergicos 5-ht /5-ht |
IT1291569B1 (it) * | 1997-04-15 | 1999-01-11 | Angelini Ricerche Spa | Indazolammidi come agenti serotoninergici |
TW402591B (en) * | 1997-07-11 | 2000-08-21 | Janssen Pharmaceutica Nv | Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
US5914405A (en) * | 1997-10-07 | 1999-06-22 | Eli Lilly And Company | Process for preparing 3-substituted indazoles |
US6069152A (en) * | 1997-10-07 | 2000-05-30 | Eli Lilly And Company | 5-HT4 agonists and antagonists |
FR2769915B1 (fr) | 1997-10-21 | 2000-10-13 | Synthelabo | Derives d'indazole tricycliques, leur preparation et leur application en therapeutique |
IT1298271B1 (it) | 1998-02-18 | 1999-12-20 | Boehringer Ingelheim Italia | Esteri ed ammidi dell'acido 2-oxo-2,3-diidro-benzimidazol-1- carbossilico |
HUP0101511A3 (en) * | 1998-04-28 | 2002-12-28 | Dainippon Pharmaceutical Co | 1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
DE69935600T2 (de) * | 1998-09-10 | 2007-12-06 | F. Hoffmann-La Roche Ag | Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten |
TW570920B (en) * | 1998-12-22 | 2004-01-11 | Janssen Pharmaceutica Nv | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders |
FR2792318B1 (fr) | 1999-04-16 | 2001-06-15 | Synthelabo | Derives d'indazole, leur preparation et leur application en therapeutique |
EP1173168A2 (fr) * | 1999-04-28 | 2002-01-23 | Respiratorius AB | Un compose pour l'utilisation d'un medicament destine au traitement de troubles de contraction bronchique |
ES2154605B1 (es) | 1999-09-14 | 2001-11-16 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
IT1313625B1 (it) * | 1999-09-22 | 2002-09-09 | Boehringer Ingelheim Italia | Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina. |
IT1313660B1 (it) | 1999-10-01 | 2002-09-09 | Dompe Spa | Procedimento stereoselettivo per la preparazione di endo-3-amminoazabicicloalcani. |
WO2002036113A1 (fr) | 2000-11-01 | 2002-05-10 | Respiratorius Ab | Composition comprenant des agonistes (5ht-4) et des antagonistes (5ht-2, 5ht-3) recepteurs de la serotonine |
US6624162B2 (en) * | 2001-10-22 | 2003-09-23 | Pfizer Inc. | Imidazopyridine compounds as 5-HT4 receptor modulators |
MXPA03000145A (es) * | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
US6696468B2 (en) * | 2002-05-16 | 2004-02-24 | Dainippon Pharmaceutical Co., Ltd. | (s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofuryl-carbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor |
CA2499494A1 (fr) | 2002-09-20 | 2004-04-01 | Pfizer Inc. | Composes de piperidinyl-imidazopyridine n-substitues utilises comme modulateurs du recepteur 5-ht4 |
DOP2003000703A (es) * | 2002-09-20 | 2004-03-31 | Pfizer | Compuestos de imidazopiradina como agonistas del receptor 5-ht4 |
EP1620435A1 (fr) * | 2003-04-21 | 2006-02-01 | Pfizer Inc. | COMPOSES IMIDAZOPYRIDIQUES AYANT UNE ACTIVITE AGONISTE ANTI-RECEPTEUR 5-HT sb 4 /sb ET UNE ACTIVITE ANTAGONISTE ANTI-RECEPTEUR 5-HT sb 3 /sb |
EP2305254A1 (fr) | 2003-06-19 | 2011-04-06 | Janssen Pharmaceutica NV | 4-(aminomethyl)-piperidine benzamides substitués par un groupe aminosulfonyle comme antagonistes de 5HT4 pour le traitement des troubles gastrointestinaux |
JO2478B1 (en) | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
AP2184A (en) | 2003-09-03 | 2010-12-02 | Pfizer | Benzimidazolone compounds having 5-HT4 receptor agonistic activity. |
US7964727B2 (en) | 2003-11-24 | 2011-06-21 | Pfizer Inc. | Quinolonecarboxylic acid compounds having 5-HT4 receptor agonistic activity |
JP4859672B2 (ja) | 2004-01-29 | 2012-01-25 | ファイザー株式会社 | 5−ht4受容体作動活性を有する1−イソプロピル−2−オキソ−1,2−ジヒドロピリジン−3−カルボキサミド誘導体 |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
WO2005092882A1 (fr) | 2004-03-01 | 2005-10-06 | Pfizer Japan, Inc. | Derives de 4-amino-5-halogeno-benzamide utiles comme agonistes du recepteur 5-ht4 dans le traitement des troubles gastro-intestinaux, du systeme nerveux central, neurologiques et cardio-vasculaires |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) * | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
EP1758891A2 (fr) * | 2004-06-15 | 2007-03-07 | Pfizer Japan Inc. | Derives de benzimidazolone d'acide carboxylique |
JP5086091B2 (ja) * | 2004-11-05 | 2012-11-28 | セラヴァンス, インコーポレーテッド | 5−ht4受容体アゴニスト化合物 |
JP5042028B2 (ja) * | 2004-11-05 | 2012-10-03 | セラヴァンス, インコーポレーテッド | キノリノン−カルボキサミド化合物 |
EP1902053B1 (fr) * | 2005-06-07 | 2011-01-12 | Theravance, Inc. | Composes de benzoimidazolone-carboxamide en tant qu'agonistes du recepteur 5-ht4 |
-
2005
- 2005-12-21 JP JP2007548417A patent/JP5159317B2/ja not_active Expired - Fee Related
- 2005-12-21 DE DE602005021696T patent/DE602005021696D1/de active Active
- 2005-12-21 MX MX2007007818A patent/MX2007007818A/es active IP Right Grant
- 2005-12-21 KR KR1020077016579A patent/KR20070091665A/ko not_active Application Discontinuation
- 2005-12-21 US US11/314,591 patent/US7419989B2/en active Active
- 2005-12-21 AT AT05854933T patent/ATE469897T1/de not_active IP Right Cessation
- 2005-12-21 BR BRPI0519708-2A patent/BRPI0519708A2/pt not_active IP Right Cessation
- 2005-12-21 CA CA002588037A patent/CA2588037A1/fr not_active Abandoned
- 2005-12-21 RU RU2007128061/04A patent/RU2404179C2/ru not_active IP Right Cessation
- 2005-12-21 NZ NZ555180A patent/NZ555180A/en not_active IP Right Cessation
- 2005-12-21 AU AU2005319190A patent/AU2005319190A1/en not_active Abandoned
- 2005-12-21 CN CNA2005800433844A patent/CN101080406A/zh active Pending
- 2005-12-21 WO PCT/US2005/046295 patent/WO2006069125A1/fr active Application Filing
- 2005-12-21 ES ES05854933T patent/ES2347265T3/es active Active
- 2005-12-21 EP EP05854933A patent/EP1831211B1/fr active Active
-
2007
- 2007-05-14 IL IL183160A patent/IL183160A0/en unknown
- 2007-06-08 MA MA29976A patent/MA29088B1/fr unknown
- 2007-06-18 ZA ZA200705115A patent/ZA200705115B/xx unknown
- 2007-06-21 NO NO20073182A patent/NO20073182L/no not_active Application Discontinuation
-
2008
- 2008-01-15 US US12/008,840 patent/US7786136B2/en not_active Expired - Fee Related
-
2010
- 2010-07-23 US US12/842,389 patent/US8003664B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
RU2404179C2 (ru) | 2010-11-20 |
US20080132491A1 (en) | 2008-06-05 |
EP1831211A1 (fr) | 2007-09-12 |
WO2006069125A1 (fr) | 2006-06-29 |
US7786136B2 (en) | 2010-08-31 |
CN101080406A (zh) | 2007-11-28 |
US7419989B2 (en) | 2008-09-02 |
US20100292223A1 (en) | 2010-11-18 |
IL183160A0 (en) | 2007-09-20 |
JP5159317B2 (ja) | 2013-03-06 |
BRPI0519708A2 (pt) | 2009-03-10 |
AU2005319190A1 (en) | 2006-06-29 |
MX2007007818A (es) | 2007-09-11 |
KR20070091665A (ko) | 2007-09-11 |
ZA200705115B (en) | 2008-06-25 |
US20060135764A1 (en) | 2006-06-22 |
ES2347265T3 (es) | 2010-10-27 |
NZ555180A (en) | 2010-09-30 |
JP2008525466A (ja) | 2008-07-17 |
NO20073182L (no) | 2007-08-28 |
RU2007128061A (ru) | 2009-01-27 |
CA2588037A1 (fr) | 2006-06-29 |
US8003664B2 (en) | 2011-08-23 |
EP1831211B1 (fr) | 2010-06-02 |
ATE469897T1 (de) | 2010-06-15 |
DE602005021696D1 (de) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA29088B1 (fr) | Composes d'indazole-carboxamide. | |
ATE441646T1 (de) | 5-ht4-rezeptoragonistenverbindungen | |
ATE431824T1 (de) | Chinolinon-carboxamid-verbindungen | |
MY155036A (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
WO2006133104A3 (fr) | Composes de benzoimidazolone-carboxamide en tant qu'agonistes du recepteur 5-ht4 | |
BRPI0507791A (pt) | compostos de indazol-carboxamida como agonistas do receptor 5-ht4 | |
WO2005121065A3 (fr) | Agonistes des recepteurs $g(b)2-adrenergiques diaminiques | |
TW200531692A (en) | Aryl aniline derivatives as β2 adrenergic receptor agonists | |
TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
MX2009006339A (es) | Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide. | |
TW200608960A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
CR9304A (es) | Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos | |
WO2006031556A3 (fr) | Composes d'arylaniline a substitution amidine | |
TW200608966A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
UA83917C2 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
WO2005030678A3 (fr) | Agonistes ethylamino aminosubstitues du recepteur ?eta2-adrenergique | |
TW200734323A (en) | 3-Aminocyclopentanecarboxamides as modulators of chemokine receptors | |
EA200702612A1 (ru) | Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт | |
MX2007010769A (es) | Compuestos de quinolina como agonistas de receptor 5-ht4. | |
MY143574A (en) | Carbamate compounds as 5-ht4 receptor agonists | |
UA83142C2 (en) | 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors |